Selecting Screening Candidates for Kinase and G Protein-Coupled Receptor Targets Using Neural Networks
暂无分享,去创建一个
Martyn G. Ford | David C. Whitley | Emanuela Gancia | David J. Livingstone | David T. Manallack | Will R. Pitt | John G. Montana | D. Manallack | D. Livingstone | W. Pitt | E. Gancia | J. Montana | M. Ford | D. Whitley
[1] F. Burden. Molecular Identification Number for Substructure Searches. , 1989 .
[2] Stephen D. Pickett,et al. Diversity Profiling and Design Using 3D Pharmacophores: Pharmacophore-Derived Queries (PDQ) , 1996, J. Chem. Inf. Comput. Sci..
[3] J. Mason,et al. New perspectives in lead generation II: Evaluating molecular diversity , 1996 .
[4] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[5] G. Rishton. Reactive compounds and in vitro false positives in HTS , 1997 .
[6] C. Hulme,et al. Inhibitors of Tyrosine Kinases Involved in Inflammation and Autoimmune Disease , 1997 .
[7] Ajay,et al. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.
[8] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[9] Jonathan S. Mason,et al. Chemistry Space Metrics in Diversity Analysis, Library Design, and Compound Selection , 1998, J. Chem. Inf. Comput. Sci..
[10] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[11] P. Willett,et al. Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms. , 1998 .
[12] K. M. Smith,et al. Novel software tools for chemical diversity , 1998 .
[13] Mark A. Murcko,et al. Virtual screening : an overview , 1998 .
[14] F. Burden,et al. New QSAR Methods Applied to Structure—Activity Mapping and Combinatorial Chemistry. , 1999 .
[15] Robert S. Pearlman,et al. Metric Validation and the Receptor-Relevant Subspace Concept , 1999, J. Chem. Inf. Comput. Sci..
[16] J. Mason,et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.
[17] Ajay,et al. Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.
[18] G. Bemis,et al. Properties of known drugs. 2. Side chains. , 1999, Journal of medicinal chemistry.
[19] D. Boschelli. Small molecule inhibitors of receptor tyrosine kinases , 1999 .
[20] Schmid,et al. "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.
[21] J. Bajorath,et al. Database Searching for Compounds with Similar Biological Activity Using Short Binary Bit String Representations of Molecules. , 1999 .
[22] D. Schnur. Design and Diversity Analysis of Large Combinatorial Libraries Using Cell‐Based Methods. , 1999 .
[23] J. Wang,et al. Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds. , 1999, Journal of combinatorial chemistry.
[24] Brian Hudson,et al. Strategic Pooling of Compounds for High-Throughput Screening , 1999, J. Chem. Inf. Comput. Sci..
[25] Stephen D. Pickett,et al. Classification of Kinase Inhibitors Using BCUT Descriptors , 2000, J. Chem. Inf. Comput. Sci..
[26] G M Keserû,et al. A neural network based virtual high throughput screening test for the prediction of CNS activity. , 2000, Combinatorial chemistry & high throughput screening.
[27] S. Venkatesh,et al. Role of the development scientist in compound lead selection and optimization. , 2000, Journal of pharmaceutical sciences.
[28] T N Thompson,et al. Early ADME in support of drug discovery: the role of metabolic stability studies. , 2000, Current drug metabolism.
[29] A Bucinski,et al. Pharmacological classification of drugs based on neural network processing of molecular modeling data. , 2000, Combinatorial chemistry & high throughput screening.
[30] J. Mason,et al. Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity. , 2000, Journal of molecular graphics & modelling.
[31] Johnson,et al. Predicting human safety: screening and computational approaches. , 2000, Drug discovery today.
[32] Martyn G. Ford,et al. Unsupervised Forward Selection: A Method for Eliminating Redundant Variables , 2000, J. Chem. Inf. Comput. Sci..
[33] J. Mason,et al. Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity. , 2000, Journal of molecular graphics & modelling.
[34] U. Lessel,et al. In vitro and in silico affinity fingerprints: Finding similarities beyond structural classes , 2000 .
[35] M. Wagener,et al. Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features. , 2000 .
[36] Jun Xu,et al. Drug-like Index: A New Approach To Measure Drug-like Compounds and Their Diversity , 2000, J. Chem. Inf. Comput. Sci..
[37] Jürgen Bajorath,et al. Molecular Descriptors for Effective Classification of Biologically Active Compounds Based on Principal Component Analysis Identified by a Genetic Algorithm , 2000, J. Chem. Inf. Comput. Sci..
[38] Robert Bywater,et al. Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds , 2000, J. Chem. Inf. Comput. Sci..
[39] I. Muegge,et al. Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.
[40] Darren V. S. Green,et al. Prediction of Biological Activity for High-Throughput Screening Using Binary Kernel Discrimination , 2001, J. Chem. Inf. Comput. Sci..
[41] J. Drews. Jürgen Drews discusses the future of the industry. Interviewed by Rebecca N. Lawrence. , 2001, Drug discovery today.
[42] D. E. Clark,et al. Prediction of intestinal absorption and blood-brain barrier penetration by computational methods. , 2001, Combinatorial chemistry & high throughput screening.
[43] D. Kassel. Combinatonial chemistry and mass spectrometry in the 21st century drug discovery laboratory. , 2001, Chemical reviews.
[44] D. Kassel. Combinatorial Chemistry and Mass Spectrometry in the 21st Century Drug Discovery Laboratory , 2001 .
[45] R. García-Domenech,et al. General topological patterns of known drugs. , 2001, Journal of molecular graphics & modelling.
[46] Hua Gao,et al. Application of BCUT Metrics and Genetic Algorithm in Binary QSAR Analysis , 2001, J. Chem. Inf. Comput. Sci..
[47] J. Mason,et al. The design of combinatorial libraries using properties and 3D pharmacophore fingerprints. , 2001, Drug discovery today.
[48] J. Wölcke,et al. Miniaturized HTS technologies - uHTS. , 2001, Drug discovery today.
[49] S. Anzali,et al. Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). , 2001, Journal of medicinal chemistry.
[50] Jun Xu,et al. Drug-Like Index: A New Approach to Measure Drug-Like Compounds and Their Diversity. , 2001 .
[51] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[52] J. Gittins,et al. Prediction of Biological Activity for High-Throughput Screening Using Binary Kernel Discrimination. , 2001 .
[53] A. Li,et al. Screening for human ADME/Tox drug properties in drug discovery. , 2001, Drug discovery today.
[54] Á. Furka. Combinatorial chemistry: 20 years on... , 2002, Drug discovery today.
[55] Gert Vriend,et al. GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..